{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:20:27Z","timestamp":1771003227814,"version":"3.50.1"},"reference-count":16,"publisher":"Maad Rayan Publishing Company","issue":"Suppl 1","content-domain":{"domain":["journals.tbzmed.ac.ir"],"crossmark-restriction":false},"short-container-title":["Adv Pharm Bull"],"DOI":"10.15171\/apb.2015.088","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T14:12:36Z","timestamp":1451571156000},"page":"649-652","update-policy":"https:\/\/doi.org\/10.15171\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Molecular Targeting of Her-2\/neu Protein Is Not Recommended as an Adjuvant Therapy in Oral Squamous Cell Carcinoma and Oral Lichen Planus"],"prefix":"10.34172","volume":"5","author":[{"given":"Maryam","family":"Kouhsoltani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirala","family":"Aghbali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrooz","family":"Shokoohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronak","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"20123","published-online":{"date-parts":[[2015,12,31]]},"reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2003.S1079210403001616"},{"key":"R2","unstructured":"Regezi JA, Sciubba JJ, Jordan RC. Oral pathology: Clinical pathologic correlations. 6th ed. St Louis: Saunders Elsevier; 2011."},{"key":"R3","unstructured":"\u200f Neville B, Damm DD, Allen CM. Oral and maxillofacial pathology\u200f. 4th ed. St Louis: Saunders Elsevier; 2016."},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2007.08.001"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2010.06.022"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2009.00764.x"},{"key":"R7","unstructured":"Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and cotran pathologic basis of disease. 9th ed. Philadelphia:Saunders Elsevier; 2014."},{"key":"R8","first-page":"4164","article-title":"Combination of egfr, her-2\/neu, and her-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members","volume":"5","author":"\u200f Xia W","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R9","first-page":"540","article-title":"Characterization of the her-2\/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma","volume":"8","author":"\u200f Khan AJ","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R10","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.7314\/APJCP.2012.13.6.2891","article-title":"Her2\/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated","volume":"13","author":"Sardari Y","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"R11","first-page":"2958","article-title":"A novel approach in the treatment of cancer: Targeting the epidermal growth factor receptor","volume":"7","author":"Ciardiello F","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2007.00502.x"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1111\/jop.12173"},{"key":"R14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1200\/JCO.2001.19.2.354","article-title":"Her-2\/neu analysis in archival tissue samples of human breast cancer: Comparison of immunohistochemistry and fluorescence in situ hybridization","volume":"19","author":"\u200f Lebeau A","year":"2001","journal-title":"J Clin Oncol"},{"key":"R15","first-page":"5675","article-title":"Amplification and overexpression of her-2\/neu in carcinomas of the salivary gland: Correlation with poor prognosis","volume":"54","author":"Press MF","year":"1994","journal-title":"Cancer Res"},{"key":"R16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the her-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"\u200f Slamon DJ","year":"1989","journal-title":"Science"}],"container-title":["Advanced Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.tbzmed.ac.ir\/APB\/manuscript\/APB-5-649.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T21:09:55Z","timestamp":1581714595000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.tbzmed.ac.ir\/APB\/Abstract\/APB_2659_20150607183852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,31]]},"references-count":16,"journal-issue":{"issue":"Suppl 1","published-online":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.15171\/apb.2015.088","relation":{},"ISSN":["2228-5881","2251-7308"],"issn-type":[{"value":"2228-5881","type":"print"},{"value":"2251-7308","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,31]]}}}